PCM
ARRY

Pentwater Capital Management’s Array Biopharma Inc ARRY Stock Holding History

Pentwater Capital Management’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-2,765,000
Closed -$128M – 231
2019
Q2 		$128M Buy
+2,765,000
New +$77.6M 1.38% 16

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Pentwater Capital Management's ARRY Position: Q3 2019 in Review

Pentwater Capital Management sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 2,765,000 shares — an estimated $128M sold.

Pentwater Capital Management first reported a position in ARRY in Q2 2019 and held it in 1 quarter. The position peaked at $128M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • Pentwater Capital Management reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • Pentwater Capital Management sold 2,765,000 Array Biopharma Inc shares in Q3 2019, an estimated $128M.
  • Pentwater Capital Management first reported a position in Array Biopharma Inc in Q2 2019 and held it in 1 quarter.
  • Pentwater Capital Management's Array Biopharma Inc position peaked at $128M in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Pentwater Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.